Owkin (Group)

https://www.owkin.com

LinkedIn: https://www.linkedin.com/company/owkin

Owkin is the first end-to-end TechBio company on a mission to understand complex biology and derive new multimodal biomarkers through AI. We identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics using AI trained on world-class patient data through privacy-enhancing federated technologies. We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, immunity and inflammation. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like Fidelity, GV and Bpifrance, among others. *

	Start	2016-01-01 established
	Industry	artificial intelligence (AI) / machine learning (ML)
	Industry 2	Owkin Socrates
	Person	Clozel, Thomas (Owkin 202111 CEO + Co-Founder)

	Region	Paris
	Country	France
	Street	12 Rue Martel
	City	75010 New York, NY
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology".

		Record changed: 2024-03-30